IndiaTickerAnalysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories LimitedNSE · conference call · pdf
Source filing Company dossier
Divis Laboratories
NSE:DIVISLAB · ISIN INE361B01024
- Close
- ₹7,784.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Divis Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Copy of Newspaper Publication - Divi's Laboratories LimitedNSE · exchange filing · pdf
Archived filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Notice Of 36Th Annual General Meeting To Be Held On August 10, 2026BSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Shareholders meeting - Divi's Laboratories LimitedNSE · exchange filing · pdf
Archived filing Copy of Newspaper Publication - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Trading Window - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Updates - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26BSE · corporate action · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing Copy of Newspaper Publication - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories LimitedNSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Outcome Of Board Meeting Held On May 23, 2026BSE · financial results · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Divi's Laboratories LimitedNSE · financial results · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Dividend UpdatesBSE · corporate action · pdf
Source filing Divis Laboratories Ltd - 532488 - Outcome Of Board Meeting - Dividend RecommendedBSE · corporate action · pdf
Source filing Divis Laboratories Ltd - 532488 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 23, 2026BSE · exchange filing · pdf
Source filing Dividend - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Record Date - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Divi's Laboratories LimitedNSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories LimitedNSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Divi's Laboratories LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Divi's Laboratories LimitedNSE · conference call · pdf
Source filing Divis Laboratories Ltd - 532488 - Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, For The Financial Year 2025-26.BSE · financial results · pdf
Source filing